Search - tctmd.com

Displaying 761 - 780 of 995

Sort: Relevancy | Date

News Industry News

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent Following CE Mark

November 02, 2014

News Industry News

Medtronic Begins Global Clinical Study of Investigational Pericardial Surgical Aortic Heart Valve

October 28, 2014

News Daily News

Preexisting—But Not New-Onset—A-fib Predicts Worse Long-term Outcomes After TAVR

October 17, 2014

News Industry News

Medtronic CoreValve System Shows Exceptional Outcomes and Valve Performance in TAVI Patients Treated Via Direct Aortic Access

October 13, 2014

News Daily News

Registry Study: Survival Benefit for Treating CTO After Primary PCI

Todd Neale

October 10, 2014

News Daily News

PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation

October 10, 2014

News Industry News

FDA Advisory Committee Panel Votes In Favor Of The WATCHMAN™ Left Atrial Appendage Closure Device

October 08, 2014

News Industry News

Medtronic Drug-Coated Balloon Shows Strong Clinical and Economic Benefit in Treatment of Peripheral Artery Disease

September 16, 2014

News Conference News TCT 2014

VELOCITY: Hypothermia for STEMI Results in More Adverse Events, No Reductions in Infarct Size

September 15, 2014

News Industry News

New Study Finds Systemic Hypothermia does not Improve Outcomes for Heart Attack Patients

September 15, 2014

News Industry News

Medtronic Launches SEEQ(TM) Wearable Cardiac Monitoring System in United States

September 15, 2014

News Industry News

St. Jude Medical Nanostim Leadless Pacemaker Receives Prestigious Award at the Annual Phoenix Conference

September 15, 2014

Presentation TCT 2014

Renal Denervation for Atrial and Ventricular Arrhythmias: Status and Case Examples

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, Vivek Y. Reddy

September 14, 2014

News Industry News

Medtronic CoreValve System Sustains Positive Outcomes Through Two Years in Extreme Risk Patients

September 13, 2014

News Industry News

Medtronic CoreValve Data Demonstrate Favorable Cost Effectiveness Compared to Open-Heart Surgery in High Risk Patients

September 13, 2014

News Conference News TCT 2014

Bleeding, Arrhythmias Dominate Periprocedural Complication Costs for TAVR

September 13, 2014

News Industry News

Medtronic NC Euphora(TM) Coronary Balloon Receives FDA Clearance

September 11, 2014

News Industry News

Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R

September 10, 2014

News Conference News ESC 2014

RITA-3: Advantage of Routine Invasive Strategy for NSTE-ACS Gone by 10 Years

Caitlin E. Cox

September 03, 2014

News Industry News

Medtronic Announces CE Mark for Recapturable CoreValve Evolut R System

September 03, 2014

Advertisement

Medtronic Launches Resolute Onyx(TM) Drug-Eluting Stent Following CE Mark

Medtronic Begins Global Clinical Study of Investigational Pericardial Surgical Aortic Heart Valve

Preexisting—But Not New-Onset—A-fib Predicts Worse Long-term Outcomes After TAVR

Medtronic CoreValve System Shows Exceptional Outcomes and Valve Performance in TAVI Patients Treated Via Direct Aortic Access

Registry Study: Survival Benefit for Treating CTO After Primary PCI

PARTNER Data Provide More Evidence of Mortality Impact of Post-TAVR Regurgitation

FDA Advisory Committee Panel Votes In Favor Of The WATCHMAN™ Left Atrial Appendage Closure Device

Medtronic Drug-Coated Balloon Shows Strong Clinical and Economic Benefit in Treatment of Peripheral Artery Disease

VELOCITY: Hypothermia for STEMI Results in More Adverse Events, No Reductions in Infarct Size

New Study Finds Systemic Hypothermia does not Improve Outcomes for Heart Attack Patients

Medtronic Launches SEEQ(TM) Wearable Cardiac Monitoring System in United States

St. Jude Medical Nanostim Leadless Pacemaker Receives Prestigious Award at the Annual Phoenix Conference

Renal Denervation for Atrial and Ventricular Arrhythmias: Status and Case Examples

Medtronic CoreValve System Sustains Positive Outcomes Through Two Years in Extreme Risk Patients

Medtronic CoreValve Data Demonstrate Favorable Cost Effectiveness Compared to Open-Heart Surgery in High Risk Patients

Bleeding, Arrhythmias Dominate Periprocedural Complication Costs for TAVR

Medtronic NC Euphora(TM) Coronary Balloon Receives FDA Clearance

Medtronic Announces First U.S. Implants in Clinical Study of Recapturable CoreValve Evolut R

RITA-3: Advantage of Routine Invasive Strategy for NSTE-ACS Gone by 10 Years

Medtronic Announces CE Mark for Recapturable CoreValve Evolut R System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content